TCWM
TCON

Total Clarity Wealth Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Total Clarity Wealth Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-341
Closed -$56K – 788
2021
Q1 		$56K Buy
+341
New +$65.7K 0.03% 322

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Total Clarity Wealth Management's TCON Position: Q2 2021 in Review

Total Clarity Wealth Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2021, closing a stake of 341 shares — an estimated $56K sold.

Total Clarity Wealth Management first reported a position in TCON in Q1 2021 and held it in 1 quarter. The position peaked at $56K in Q1 2021. 44 funds tracked by Wall St. Rank hold TCON as of Q2 2021.

  • Total Clarity Wealth Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 341 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $56K.
  • Total Clarity Wealth Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Total Clarity Wealth Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $56K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Total Clarity Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.